S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea flag South Korea · Delayed Price · Currency is KRW
34,600
+150 (0.44%)
At close: Apr 28, 2026

S.Biomedics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Market Capitalization
428,525453,470203,202130,376--
Upgrade
Market Cap Growth
60.72%123.16%55.86%---
Upgrade
Enterprise Value
434,118456,739206,789133,226--
Upgrade
Last Close Price
34600.0037950.0017300.0011500.00--
Upgrade
PS Ratio
25.9027.4014.809.95--
Upgrade
PB Ratio
25.6227.1111.1010.55--
Upgrade
P/TBV Ratio
51.3354.3117.7418.92--
Upgrade
EV/Sales Ratio
26.2327.6015.0610.16--
Upgrade
Debt / Equity Ratio
0.730.731.030.9713.331.78
Upgrade
Net Debt / Equity Ratio
-0.15-0.15-0.280.116.16-1.58
Upgrade
Net Debt / EBITDA Ratio
0.390.391.39-0.30-2.851.91
Upgrade
Net Debt / FCF Ratio
0.290.291.06-0.17-0.511.61
Upgrade
Asset Turnover
0.390.390.360.470.570.50
Upgrade
Inventory Turnover
4.264.262.993.335.146.18
Upgrade
Quick Ratio
1.331.332.201.670.753.19
Upgrade
Current Ratio
1.611.612.492.050.953.44
Upgrade
Return on Equity (ROE)
-40.30%-40.30%-37.96%-138.29%-195.41%-121.47%
Upgrade
Return on Assets (ROA)
-12.15%-12.15%-8.89%-13.30%-11.13%-16.13%
Upgrade
Return on Capital Employed (ROCE)
-28.90%-28.90%-16.60%-24.70%-30.00%-34.00%
Upgrade
Earnings Yield
-1.90%-1.79%-3.29%-7.92%--
Upgrade
FCF Yield
-2.00%-1.89%-2.41%-6.13%--
Upgrade
Buyback Yield / Dilution
-3.22%-3.22%-5.22%-6.97%-0.67%-0.42%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.